Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wald, D.S.
Right arrow Articles by Gray, H.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wald, D.S.
Right arrow Articles by Gray, H.H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2003; 96: 380-382
© 2003 Association of Physicians

Correspondence

Restrictive cardiomyopathy in systemic amyloidosis

D.S. Wald and H.H. Gray

Department of Cardiology, Southampton General Hospital, Southampton e-mail: davidwald@hotmail.com

The first 10% of the full text of this article appears below.

Sir, Amyloidosis is a heterogeneous disease characterized by the deposition of an abnormal fibrillar protein (amyloid) in various tissues. Amyloid cardiomyopathy, due to amyloid infiltration of the myocardium can occur in all forms of systemic amyloid. It is a serious medical disorder with an average survival of <6 months.1 We report a case of restrictive cardiomyopathy secondary to systemic AL amyloidosis that illustrates how recent developments in diagnosis, monitoring and treatment of the disorder can substantially improve prognosis.

A 47-year-old man who had been well 6 months previously, was . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
R. Y. Kwong and R. H. Falk
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis
Circulation, January 18, 2005; 111(2): 122 - 124.
[Full Text] [PDF]